Skip to content

XBIO REPORT

FREE WEEKLY BIOTECH STOCK CATALYST REPORTS
CONTACT

Tag: Bio-Thera Solutions

May 18, 2026

Bio-Thera Solutions' Golimumab Biosimilars Receive FDA Approval as First Biosimilars to Simponi® and Simponi Aria®; Accord BioPharma to Commercialize IMMGOLIS™ (golimumab-sldi) and IMMGOLIS INTRI™ (golimumab-sldi) in the United States

Source: Read More

Announcements, FDA Acceptance

Bio-Thera Solutions, golimumab, golimumab-sldi, IMMGOLIS, pr-newswire, Simponi

© XBioReport.com

Disclaimer: This site is for information only. Not investment advice.

Get FREE Biotech Stock Catalyst Reports

Email

Notify me about related content and special offers.

Yes No

If you opt in above, we use this information to send related content, discounts, and other special offers.